Otsuka, Lundbeck’s Rexulti nabs new use in Alzheimer’s disease agitation zbecker Thu, 05/11/2023 – 11:22 More: Otsuka, Lundbeck's Rexulti nabs new use in Alzheimer's disease agitation Source: fierce
read moreAfter Shkreli’s run in with the law, Pharma Bro’s former company Vyera files for bankruptcy fkansteiner Thu, 05/11/2023 – 11:06 More: After Shkreli's run in with the law, Pharma Bro's former company Vyera files for bankruptcy Source: fierce
read moreDespite rough quarter, Bayer’s duo of Nubeqa and Kerendia continue to excel kdunleavy Thu, 05/11/2023 – 10:52 More: Despite rough quarter, Bayer's duo of Nubeqa and Kerendia continue to excel Source: fierce
read moreMirati’s KRAS drug beats estimates in Q1, but Keytruda combo plan remains unclear aliu Thu, 05/11/2023 – 10:36 More: Mirati's KRAS drug beats estimates in Q1, but Keytruda combo plan remains unclear Source: fierce
read moreFTC targets digital pharma ads as IQVIA-Propel Media deal in regulator’s crosshairs badams Thu, 05/11/2023 – 09:27 More: FTC targets digital pharma ads as IQVIA-Propel Media deal in regulator's crosshairs Source: fierce
read moreTreatment concerns patients with IDH1-mutated acute myeloid leukaemia and IDH1-mutated cholangiocarcinoma More: European Commission green lights Servier’s Tibsovo Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals